Weiying Ma
马维英
elsewhere's corpus does not cover this subject. The search results only surface passing mentions in articles about other companies and investors, with no substantive material about who Weiying Ma is.
AI-generated — may contain errors, please verify.
Coverage
Exclusive Interview with Professor Nie Zaiqing: Is the Biopharma Version of "AI Lobster" Here? Shuimu Molecular's Dual-Wheel Model of "Proprietary Pipeline + Tool Empowerment" | Tong's Family
An **AIR incubated company and Tongtou Family portfolio company**, **Shuimu Molecular** has emerged as one of the most promising benchmark enterprises in AI-driven drug discovery, pursuing a dual-engine strategy of "tool empowerment + proprietary pipeline development." Its core achievements include the ChatDD intelligent agent framework, the OpenBioMed open-source platform, Shuimu Zhiliao — a new consumer-facing "super brain" tool for life sciences — and multimodal large models.
Beijing Launches BAAI Action Plan; Source Code Capital Investment Partner Hongjiang Zhang Named First Chairman
Support Scientists in Bravely Venturing into AI's Uncharted Frontier
Meituan Files for IPO, Three Companies Close Funding Rounds, Code Brain's Sixth Session Visits ByteDance | Ma Hui Journal · June
【Source Code Capital Chronicle】A place to record our teammates' small steps forward, share the joy of growth, and look toward an even brighter future.
2018 Global Top 1000 Computer Scientists by H-Index Released, Hongjiang Zhang Ranks First in Mainland China
Top Scientists in Computer Science and Electronics 2018
